Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Public Sector Pension Investment Board

Public Sector Pension Investment Board cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.6% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 179,380 shares of the medical equipment provider’s stock after selling 21,183 shares during the quarter. Public Sector Pension Investment Board’s holdings in Intuitive Surgical were worth $88,842,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $26,000. Chilton Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Global Financial Private Client LLC boosted its holdings in shares of Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 38 shares during the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at $26,000. Finally, LFA Lugano Financial Advisors SA acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 0.1%

ISRG stock opened at $470.08 on Monday. The firm has a 50 day simple moving average of $516.52 and a 200-day simple moving average of $528.23. The company has a market capitalization of $168.51 billion, a P/E ratio of 65.56, a PEG ratio of 4.93 and a beta of 1.59. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period last year, the business earned $1.78 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 7,893 shares of the business’s stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $498.64, for a total value of $3,935,765.52. Following the completion of the sale, the insider owned 13,187 shares of the company’s stock, valued at $6,575,565.68. This trade represents a 37.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,881 shares of company stock worth $7,920,634. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on ISRG shares. UBS Group lifted their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a report on Wednesday, July 23rd. Citigroup reaffirmed a “buy” rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, July 26th. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Finally, Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.